Latest Autolomous News & Updates
See the latest news and media coverage for Autolomous. We track all announcements, press releases, and industry mentions in real time, all in one place.
Data management platform for advanced therapy manufacturers
autolomous.com- Headquarters
- London, United Kingdom
- Founded year
- 2019
- Company type
- Private company
- Number of employees
- 30–50
Latest news about Autolomous
Company announcements
-
FDA grants accelerated approval to first gene therapy for LAD-I
Kresladi treats children with severe Leukocyte Adhesion Deficiency Type I, a rare immune disorder. Autolomous celebrates this milestone for CGT sector.
-
Autolomous CEO discusses collaboration at Meeting on the Mesa 2025
Alexander Seyf talks with IBTV about the Digital Pioneer Program with Adva Biotechnology and GenCART for decentralized cell therapy manufacturing.
-
Autolomous CEO discusses white paper with CGT Catapult
At Meeting on the Mesa 2025, Alexander Seyf talks to IBTV about a joint white paper from two-year collaboration on digital transformation in CGT.
-
Autolomous and Adva launch Digital PIONEER Program
GenCART joins as first clinical participant to validate decentralized cell therapy manufacturing. The program integrates automation and cloud software for scalable production.
Media coverage
-
Adva Biotechnology and Autolomous Launch the Digital PIONEER Program To Enable Decentralized, Scalable Cell Therapy Manufacturing
Adva Biotechnology Ltd. and Autolomous Ltd. announced the launch of the Digital PIONEER Program, a joint initiative aimed at digitizing, decentralizing, and scaling out autologous...
-
Autolomous Releases the CGT Industry's First Free Electronic Batch Record Builder
Autolomous, announces the market availability of autoloMATE Launchpad. This free, self-service platform enables teams of any resource level across CGT manufacturing to integrate digital planning...
-
Autolomous and BioCentriq Partner to Speed Up Cell Therapy Delivery
LONDON and NEWARK, N.J., April 24, 2024 /PRNewswire/ -- Autolomous, the market-leading developer of critical manufacturing management systems for cell and gene therapies, and BioCentriq...
-
Autolomous and the Cell and Gene Therapy Catapult awarded £1.2m grant by UK Research and Innovation
This grant will fund a two-year project to digitise Process Analytical Technologies and accelerate industrial scale cell and gene therapy manufacturing London, UK, 12 June...
Track Autolomous and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group
FAKRO